个人简介

In 1966 Ursula Quitterer was born in Passau, Germany. She studied pharmaceutical sciences in Regensburg and obtained a Ph.D. degree in 1994 from the University of Mainz. After a postdoctorate at Roche Biosciences Inc. in Palo Alto (USA), she joined the Institute of Pharmacology at the University of Würzburg (Deutschland) as a senior scientist. In 1999 she was awarded the "Bayerische Habilitationsförderpreis". Research visits at Medigene Inc. (Munich) and at the Heinrich-Pette-Institute of Experimental Virology and Immunology (Hamburg) followed. She achieved the habilitation for pharmacology and toxicology in 2001. From 2004 to 2005 she directed the teaching program of pharmacology and toxicology for pharmaceutical and life science students at the University of Wuerzburg.

研究领域

Molecular Pharmacology

Research interests include the pathomechanisms of cardiovascular disease and atherosclerosis with particular focus on the relationship between cardiovascular risk factors, the dysfunction of signal transduction mechanisms and end organ damage. The research aims to identify pharmacological targets and to delineate therapeutic concepts to prevent and retard the progression of cardiovascular disease.

近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Quitterer, U. and Abdalla, S. Vasopressor meets vasodepressor 2014, Biochemical pharmacology Abd Alla, Joshua and Graemer, Muriel and Quitterer, Ursula Transgenic mice with myocardium-specific overexpression of fatty acid synthase (FASN) develop signs of cardiac hypertrophy and failure 2014, Naunyn-Schmiedeberg’s Archives of Pharmacology BIB Quitterer, Ursula and Langer, Andreas and Graemer, Muriel and Abdalla, Said Transgenic mice show functional heterodimerization between vascular angiotensin II AT1 receptor and bradykinin B2 receptor 2014, Naunyn-Schmiedeberg’s archives of pharmacology : official journal of the International Sphingolipid Club Quitterer, Ursula and Abdalla, Said Analysis of AT1--B2 receptor heterodimerization in transgenic mice 2014, Experimental and clinical cardiology BIB Alla, Joshua Abd and Faramawy, Yasser el and Quitterer, Ursula Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis 2013, Frontiers in physiology Fu, Xuebin and Koller, Samuel and Abd Alla, Joshua and Quitterer, Ursula Inhibition of G-protein-coupled Receptor Kinase 2 (GRK2) Triggers the Growth-promoting Mitogen-activated Protein Kinase (MAPK) Pathway 2013, Journal of Biological Chemistry Abd Alla, Joshua and Langer, Andreas and Quitterer, Ursula and AbdAlla, Said Inhibition of the Raf1 and GRK2 Axis in Transgenic Mice with Myocardium-Specific Expression of the Raf Kinase Inhibitor Protein (RKIP) 2013, Naunyn-Schmiedeberg’s archives of pharmacology Abd Alla, Joshua and Quitterer, Ursula Microarray gene expression profiling of transgenic mice with myocardium-specific over-expression of fatty acid synthase (FASN) 2013, Gene Expression Omnibus BIB AbdAlla, Said and Langer, Andreas and Fu, Xuebin and Quitterer, Ursula ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease 2013, International journal of molecular sciences AbdAlla, Said and Quitterer, Ursula Hippocampal gene expression profiling of a model of Alzheimer`s Disease upon treatment with the ACE inhibitor captopril 2013, Gene Expression Omnibus BIB Fu, Xuebin and Abd Alla, Joshua and Langer, Andreas and Elriedy Amr and Quitterer, Ursula Myocardium-Specific Expression of the Raf Kinase Inhibitor Protein (RKIP) in Transgenic Mice Induced Signs of Heart Failure 2013, Naunyn-Schmiedeberg's archives of pharmacology : official journal of the International Sphingolipid Club BIB Langer, Andreas and AbdAlla, Said and Fu, Xuebin and Quitterer, Ursula A centrally active ACE inhibitor promotes signs of hippocampal neuroregeneration in the Tg2576 model of Alzheimer`s disease 2013, The journal of nutrition, health & aging BIB Abd Alla, Joshua and Quitterer, Ursula Microarray gene expression profiling of aortic genes of APOE-deficient mice receiving atherosclerosis treatment with the antioxidant vitamin E 2012, Gene expression omnibus BIB Abd Alla, Joshua and Quitterer, U. Microarray gene expression profiling of transgenic mice with myocardium-specific expression of RKIP or a GRK-specific peptide inhibitor 2012, NCBI GEO database BIB Abd Alla, Joshua and Quitterer, Ursula Microarray gene expression profiling of kinase-dependent and kinase-independent effects of GRK2 2012, Gene expression omnibus BIB Fu, X. and Abd Alla, Joshua and Quitterer, U. Microarray gene expression profiling reveals up-regulation of the cardiac lipid metabolic process at the onset of heart failure 2012, Naunyn-Schmiedeberg's archives of pharmacology BIB AbdAlla, Said and Fu, Xuebin and Elzahwy, Sherif S. and Klaetschke, Kristin and Streichert, Thomas and Quitterer, Ursula Up-Regulation of the Cardiac Lipid Metabolism at the Onset of Heart Failure 2011, Cardiovascular & hematological agents in medicinal chemistry Quitterer, Ursula and Pohl, Armin and Langer, Andreas and Koller, Samuel and AbdAlla, Said A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor 2011, Biochemical and biophysical research communications Abd Alla, Joshua and Quitterer, Ursula Microarray gene expression profiling of heart failure induced in apolipoprotein E-deficient mice 2011, Gene expression omnibus BIB Abd Alla, Joshua and Quitterer, U. The Antidiabetic Drug Rosiglitazone Causes Cardiac Hypertrophy and Symptoms of Heart Failure in Atherosclerosis-Prone Apolipoprotein E-Deficient Mice 2011, Naunyn-Schmiedeberg’s archives of pharmacology BIB